BioStem BSEM Stock
BioStem Price Chart
BioStem BSEM Financial and Trading Overview
| BioStem stock price | 3.66 USD |
| Previous Close | 3.54 USD |
| Open | 3.55 USD |
| Bid | 3.96 USD x 70000 |
| Ask | 3.98 USD x 250000 |
| Day's Range | 3.55 - 3.95 USD |
| 52 Week Range | 2.25 - 8.4 USD |
| Volume | 110.51K USD |
| Avg. Volume | 69.29K USD |
| Market Cap | 69.9M USD |
| Beta (5Y Monthly) | 0.257 |
| PE Ratio (TTM) | 4.4545455 |
| EPS (TTM) | 0.88 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
BSEM Valuation Measures
| Enterprise Value | 64.23M USD |
| Trailing P/E | 4.4545455 |
| Forward P/E | 13.517242 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0209956 |
| Price/Book (mrq) | 2.5290325 |
| Enterprise Value/Revenue | 1.857 |
| Enterprise Value/EBITDA | -2.919 |
Trading Information
BioStem Stock Price History
| Beta (5Y Monthly) | 0.257 |
| 52-Week Change | -34.33% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 8.4 USD |
| 52 Week Low | 2.25 USD |
| 50-Day Moving Average | 3.61 USD |
| 200-Day Moving Average | 4.47 USD |
BSEM Share Statistics
| Avg. Volume (3 month) | 69.29K USD |
| Avg. Daily Volume (10-Days) | 153.39K USD |
| Shares Outstanding | 17.83M |
| Float | 14.05M |
| Short Ratio | N/A |
| % Held by Insiders | 29.86% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -81.79% |
| Operating Margin (ttm) | -106.34% |
| Gross Margin | 79.93% |
| EBITDA Margin | -63.61% |
Management Effectiveness
| Return on Assets (ttm) | -18.070% |
| Return on Equity (ttm) | -74.74% |
Income Statement
| Revenue (ttm) | 34.59M USD |
| Revenue Per Share (ttm) | 2.04 USD |
| Quarterly Revenue Growth (yoy) | -27.90% |
| Gross Profit (ttm) | 27.65M USD |
| EBITDA | -22001998 USD |
| Net Income Avi to Common (ttm) | -28290712 USD |
| Diluted EPS (ttm) | 0.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.96M USD |
| Total Cash Per Share (mrq) | 0.39 USD |
| Total Debt (mrq) | 1.22M USD |
| Total Debt/Equity (mrq) | 4.43 USD |
| Current Ratio (mrq) | 0.98 |
| Book Value Per Share (mrq) | 1.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5919398 USD |
| Levered Free Cash Flow (ttm) | 8.68M USD |
Profile of BioStem
| Country | United States |
| State | FL |
| City | Fort Lauderdale |
| Address | 4901 Northwest 17th Way |
| ZIP | 33309 |
| Phone | 954 380 8342 |
| Website | https://biostemtechnologies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Q&A For BioStem Stock
What is a current BSEM stock price?
BioStem BSEM stock price today per share is 3.66 USD.
How to purchase BioStem stock?
You can buy BSEM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioStem?
The stock symbol or ticker of BioStem is BSEM.
Which industry does the BioStem company belong to?
The BioStem industry is Biotechnology.
How many shares does BioStem have in circulation?
The max supply of BioStem shares is 17.83M.
What is BioStem Price to Earnings Ratio (PE Ratio)?
BioStem PE Ratio is 4.15909100 now.
What was BioStem earnings per share over the trailing 12 months (TTM)?
BioStem EPS is 0.88 USD over the trailing 12 months.
Which sector does the BioStem company belong to?
The BioStem sector is Healthcare.
